Novartis announces intention to separate Sandoz business to create a standalone company by way of a 100% spin-off Read more
Enhertu approved in the US as the first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell lung cancer Read more
Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47 Read more
Servier Announces FDA Approval of TIBSOVO (ivosidenib tablets) in Combination with Azacitidine for Patients with Newly Diagnosed IDH1-mutated Acute Myeloid Leukemia Read more
Novartis Kymriah receives EC approval as first CAR-T cell therapy for adults with relapsed or refractory follicular lymphoma Read more
Dragonfly Therapeutics Announces Multi-Target Expansion of its Research Collaboration with AbbVie to Develop Novel Therapeutic Candidates for Immune-Mediated Diseases Read more